Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-022284
Filing Date
2025-03-10
Accepted
2025-03-10 17:00:03
Documents
2
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0233751-6k_polyrizon.htm 6-K 10532
2 PRESS RELEASE TITLED: "POLYRIZON INITIATES PRECLINICAL STUDIES FOR INTRANASAL NA ea023375102ex99-1_poly.htm EX-99.1 10692
  Complete submission text file 0001213900-25-022284.txt   22234
Mailing Address 12/6 BOROCHOV ST. RAANANA IL 4343306
Business Address 12/6 BOROCHOV ST. RAANANA IL 4343306 972-54-7979668
Polyrizon Ltd. (Filer) CIK: 0001893645 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42375 | Film No.: 25724612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)